Early insurance coverage of elexacaftor/tezacaftor/ivacaftor for cystic fibrosis

被引：0
|
作者：
Anderson, Ashlee [1 ]
McCoy, Lindsey [2 ]
Pettit, Rebecca S. [3 ]
Wright, Brittany A. [4 ]
Lubsch, Lisa [5 ,6 ]
机构：
[1] Sanford Hlth, Sioux Falls, SD 57105 USA
[2] Med Univ South Carolina, Charleston, SC 29425 USA
[3] IU Hlth, Riley Hosp Children, Indianapolis, IN USA
[4] Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA
[5] Southern Illinois Univ, Edwardsville Sch Pharm, Edwardsville, IL USA
[6] SSM Hlth Cardinal Glennon Childrens Hosp, Edwardsville, IL USA
来源：
PEDIATRIC PULMONOLOGY | 2021年 / 56卷 / 12期
关键词：
D O I：
10.1002/ppul.25659
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：4053 / 4054
页数：2
相关论文
共 50 条
  • [1] Elexacaftor/Tezacaftor/Ivacaftor (Trikafta) for Cystic Fibrosis
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2020, 62 (1589): : 5 - 7
  • [2] Cystic Fibrosis: Triple Therapy with Elexacaftor, Tezacaftor and Ivacaftor
    Lorenz, Judith
    PNEUMOLOGIE, 2022, 76 (03): : 153 - 153
  • [3] Tolerance of elexacaftor/tezacaftor/ivacaftor in Australians with cystic fibrosis
    Ruseckaite, Rasa
    Wark, Peter
    Pourghaderi, Ahmadreza
    Caruso, Marisa
    Ahern, Susannah
    RESPIROLOGY, 2024, 29 : 8 - 8
  • [4] Effects of elexacaftor-tezacaftor-ivacaftor discontinuation in cystic fibrosis
    Mitropoulou, Georgia
    Balmpouzis, Zisis
    Polojoux, Jerome
    Dotta-Celio, Jennifer
    Sauty, Alain
    Koutsokera, Angela
    RESPIRATORY MEDICINE AND RESEARCH, 2022, 82
  • [5] Ivacaftor-elexacaftor-tezacaftor and tacrolimus combination in cystic fibrosis
    Smith, Megan
    Ryan, Kevin J.
    Gutierrez, Hector
    Sanchez, Luz Helena Gutierrez
    Anderson, Janaina Nogueira
    Acosta, Edward P.
    Benner, Kim W.
    Guimbellot, Jennifer S.
    JOURNAL OF CYSTIC FIBROSIS, 2022, 21 (01) : E8 - E10
  • [6] Impact of elexacaftor/tezacaftor/ivacaftor on depression and anxiety in cystic fibrosis
    Zhang, Lijia
    Albon, Dana
    Jones, Marieke
    Bruschwein, Heather
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2022, 16
  • [7] Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis
    Nichols, David P.
    Paynter, Alex C.
    Heltshe, Sonya L.
    Donaldson, Scott H.
    Frederick, Carla A.
    Freedman, Steven D.
    Gelfond, Daniel
    Hoffman, Lucas R.
    Kelly, Andrea
    Narkewicz, Michael R.
    Pittman, Jessica E.
    Ratjen, Felix
    Rosenfeld, Margaret
    Sagel, Scott D.
    Schwarzenberg, Sarah Jane
    Singh, Pradeep K.
    Solomon, George M.
    Stalvey, Michael S.
    Clancy, John P.
    Kirby, Shannon
    Van Dalfsen, Jill M.
    Kloster, Margaret H.
    Rowe, Steven M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205 (05) : 529 - 539
  • [8] Elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and rare mutations
    Fainardi, Valentina
    Cresta, Federico
    Sorio, Claudio
    Melotti, Paola
    Pesce, Emanuela
    Deolmi, Michela
    Longo, Francesco
    Karina, Kleinfelder
    Esposito, Susanna
    Pisi, Giovanna
    PEDIATRIC PULMONOLOGY, 2024, 59 (12) : 3383 - 3390
  • [9] Papilledema and hypervitaminosis A after elexacaftor/tezacaftor/ivacaftor for cystic fibrosis
    Miller, Matthew J.
    Foroozan, Rod
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2022, 57 (01): : E6 - E10
  • [10] Heterogeneity in response to Elexacaftor/Tezacaftor/Ivacaftor in people with cystic fibrosis
    Alicandro, Gianfranco
    Gramegna, Andrea
    Bellino, Federica
    Sciarrabba, Sathya Calogero
    Lanfranchi, Chiara
    Contarini, Martina
    Retucci, Mariangela
    Blasi, Francesco
    JOURNAL OF CYSTIC FIBROSIS, 2024, 23 (06) : 1072 - 1079
12345